291Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients

Open Forum Infect Dis · 2014 · PMC5781705

Europe PMC

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a possible trendp = 0.09so close (0.05 < p ≤ 0.1)

There was a possible trend towards a better clinical response associated with telavancin compared with vancomycin (89% vs 72%; p = 0.09).

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.